hydrocodone / acetaminophen extended release
Drug2 tablets twice daily
Other names: ABT-712
NCT Number: NCT00298974
The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.
Looking for future studies?
Notify Me21 year–80 year
All sexes
Interventional
Phase 3
Site Ref # / Investigator 423, Birmingham, Alabama, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 tablets twice daily
Other names: ABT-712
2 tablets twice daily
Time frame: 12 weeks
Arthritis Pain Intensity measured by a 100mm Visual Analog Scale (VAS)
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Abbott
Industry
A Phase 3, Randomized, Multicenter, Double-blind Study Comparing the Analgesic Efficacy of Extended Release Hydrocodone/Acetaminophen Tablets (Vicodin CR) to Placebo in Subjects With Osteoarthritis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04095845
Arthritis, Joint Diseases
London, United Kingdom
View Trial DetailsNCT06087588
Arthritis, Joint Diseases
Poznan, Poznań, Poland
View Trial DetailsNCT04533711
Arthritis, Joint Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05164575
Arthritis, Hip Osteoarthritis
Edmonton, Alberta, Canada
View Trial Details